Brief: Myriad Genetics Q4 Operating Income USD -31.4 Million
27/02/2024 21:05
Feb 27 (Reuters) - Myriad Genetics Q4 operating expenses USD 166 million. * Q4 gross margin 68.6% * Q4 adjusted operating income USD 5.7 million * Q4 adjusted operating expenses USD 130 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple